Product Information
BISOPROLOL FUMARATE 10 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1785 per EA under NDC 65862008701. Its NADAC has been published 509 times since Nov 28, 2013.
FDA first approved this application on Dec 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Bisoprolol Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862008701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BISOPROLOL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA077910FDA Approved
12/27/2006
TE Code
AB
On Market Since
12/27/2006
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL FUMARATE 10 MG TAB has been published 509 times since Nov 28, 2013, and over the history we have for it it has declined 60.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1785 per EA |
|---|---|
| All-time high | $0.5544 (May 13, 2020) |
| All-time low | $0.1437 (Nov 20, 2024) |
| 52-week high | $0.2433 |
| 52-week low | $0.1785 |
| Median price | $0.3918 |
| Average price | $0.3714 |
| Largest weekly change | -55.3% (Nov 20, 2024) |
| Weeks tracked | 509 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BISOPROLOL FUMARATE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL FUMARATE 10 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.1785 per EA (NDC 65862008701), effective Aug 19, 2026.
How has the price of BISOPROLOL FUMARATE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL FUMARATE 10 MG TAB has declined 60.3%. It has been tracked across 509 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BISOPROLOL FUMARATE 10 MG TAB?
Since Nov 28, 2013, the NADAC for BISOPROLOL FUMARATE 10 MG TAB has ranged from a low of $0.1437 (Nov 20, 2024) to a high of $0.5544 (May 13, 2020), with a median of $0.3918 per EA.
Are there cheaper alternatives to BISOPROLOL FUMARATE 10 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL FUMARATE 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BISOPROLOL FUMARATE 10 MG TAB?
BISOPROLOL FUMARATE 10 MG TAB (NDC 65862008701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.